Business · 26/11/2008Updated: 10/17/2026 · 1 min read
FDA Announces Proposed Collection of Information for Prescription Drug Labeling
Summary
The Food and Drug Administration (FDA) is announcing a proposed collection of information for review and clearance under the Paperwork Reduction Act of 1995 (PRA), as part of its efforts to standardize medication guide requirements for prescription drug product labeling.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →